Feedblitz iconFeedblitzSep 22, 2026 ~1 min source read

The Spinoff: How Biosimilars Are Becoming Wholesalers' Next Hit Show

<a href="https://feeds.feedblitz.com/~/969467816/0/drugchannels~The-Spinoff... By Bryce Platt, PharmD For more than a decade, the answer to "Where do drug wholesalers make their money?" has been generic drugs.

The Spinoff: How Biosimilars Are Becoming Wholesalers' Next Hit Show

Share this story

Send the public story page.

Useful takeaways from this story.

By Bryce Platt, PharmD For more than a decade, the answer to "Where do drug wholesalers make their money?" has been generic drugs.

We estimate that in calendar year 2026, generic drugs will contribute 52% of total drug distribution gross profits of the Big Three wholesalers, but only 9% of drug distribution revenues.

Generic drugs are the long-running hit show that has carried wholesalers' profits for 15+ seasons.

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

By Bryce Platt, PharmD For more than a decade, the answer to "Where do drug wholesalers make their money?" has been generic drugs. We estimate that in calendar year 2026, generic drugs will contribute 52% of total drug distribution gross profits of the Big Three wholesalers, but only 9% of drug distribution revenues. Generic drugs are the long-running hit show that has carried wholesalers' profits for 15+ seasons.

How it works

  • The show is still on the air, but a supporting character is starting a spinoff.
  • Biosimilars now account for 6% of wholesalers' drug distribution revenues, but 23% of total gross profits.
  • <a href="https://feeds.feedblitz.com/~/969467816/0/drugchannels~The-Spinoff...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app